These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 36652054)

  • 21. Structure-activity relationships for 5F-MDMB-PICA and its 5F-pentylindole analogs to induce cannabinoid-like effects in mice.
    Glatfelter GC; Partilla JS; Baumann MH
    Neuropsychopharmacology; 2022 Mar; 47(4):924-932. PubMed ID: 34802041
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fatal intoxication by 5F-ADB and diphenidine: Detection, quantification, and investigation of their main metabolic pathways in humans by LC/MS/MS and LC/Q-TOFMS.
    Kusano M; Zaitsu K; Taki K; Hisatsune K; Nakajima J; Moriyasu T; Asano T; Hayashi Y; Tsuchihashi H; Ishii A
    Drug Test Anal; 2018 Feb; 10(2):284-293. PubMed ID: 28544560
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolic profiling of synthetic cannabinoid 5F-ADB by human liver microsome incubations and urine samples using high-resolution mass spectrometry.
    Yeter O; Ozturk YE
    Drug Test Anal; 2019 Jun; 11(6):847-858. PubMed ID: 30610752
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biotransformation of the New Synthetic Cannabinoid with an Alkene, MDMB-4en-PINACA, by Human Hepatocytes, Human Liver Microsomes, and Human Urine and Blood.
    Watanabe S; Vikingsson S; Åstrand A; Gréen H; Kronstrand R
    AAPS J; 2019 Dec; 22(1):13. PubMed ID: 31848852
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sensitive screening of synthetic cannabinoids using liquid chromatography quadrupole time-of-flight mass spectrometry after solid phase extraction.
    Kleis JN; Hess C; Germerott T; Roehrich J
    Drug Test Anal; 2021 Aug; 13(8):1535-1551. PubMed ID: 33884774
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Simultaneous analysis of 29 synthetic cannabinoids and metabolites, amphetamines, and cannabinoids in human whole blood by liquid chromatography-tandem mass spectrometry - A New Zealand perspective of use in 2018.
    Ong RS; Kappatos DC; Russell SGG; Poulsen HA; Banister SD; Gerona RR; Glass M; Johnson CS; McCarthy MJ
    Drug Test Anal; 2020 Feb; 12(2):195-214. PubMed ID: 31595682
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of the recently emerged synthetic cannabinoid 4F-MDMB-BINACA in "legal high" products and human urine specimens.
    Haschimi B; Mogler L; Halter S; Giorgetti A; Schwarze B; Westphal F; Fischmann S; Auwärter V
    Drug Test Anal; 2019 Sep; 11(9):1377-1386. PubMed ID: 31228224
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phase I metabolism of the carbazole-derived synthetic cannabinoids EG-018, EG-2201, and MDMB-CHMCZCA and detection in human urine samples.
    Mogler L; Franz F; Wilde M; Huppertz LM; Halter S; Angerer V; Moosmann B; Auwärter V
    Drug Test Anal; 2018 Sep; 10(9):1417-1429. PubMed ID: 29726116
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human phase-I metabolism and prevalence of two synthetic cannabinoids bearing an ethyl ester moiety: 5F-EDMB-PICA and EDMB-PINACA.
    Giorgetti A; Brunetti P; Haschimi B; Busardò FP; Pelotti S; Auwärter V
    Drug Test Anal; 2023 Mar; 15(3):299-313. PubMed ID: 36366743
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection and quantification of 5F-ADB and its methyl ester hydrolysis metabolite in fatal intoxication cases by liquid chromatography-high resolution mass spectrometry.
    Yeter O; Erol Öztürk Y
    Forensic Sci Int; 2019 Sep; 302():109866. PubMed ID: 31302415
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Death after smoking of fentanyl, 5F-ADB, 5F-MDMB-P7AICA and other synthetic cannabinoids with a bucket bong.
    Neukamm MA; Halter S; Auwärter V; Schmitt G; Giorgetti A; Bartel M
    Forensic Toxicol; 2024 Jan; 42(1):82-92. PubMed ID: 37300633
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and
    Cannaert A; Sparkes E; Pike E; Luo JL; Fang A; Kevin RC; Ellison R; Gerona R; Banister SD; Stove CP
    ACS Chem Neurosci; 2020 Dec; 11(24):4434-4446. PubMed ID: 33253529
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemical profiling of the synthetic cannabinoid MDMB-CHMICA: Identification, assessment, and stability study of synthesis-related impurities in seized and synthesized samples.
    Münster-Müller S; Hansen S; Opatz T; Zimmermann R; Pütz M
    Drug Test Anal; 2019 Aug; 11(8):1192-1206. PubMed ID: 31124282
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction of Liver Size Reduction in Zebrafish Larvae by the Emerging Synthetic Cannabinoid 4F-MDMB-BINACA and Its Impact on Drug Metabolism.
    Park YM; Dahlem C; Meyer MR; Kiemer AK; Müller R; Herrmann J
    Molecules; 2022 Feb; 27(4):. PubMed ID: 35209079
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of a new tert-leucinate class synthetic cannabinoid in powder and "spice-like" herbal incenses: Methyl 2-[[1-(5-fluoropentyl)indole-3-carbonyl]amino]-3,3-dimethyl-butanoate (5F-MDMB-PICA).
    Risseeuw MDP; Blanckaert P; Coopman V; Van Quekelberghe S; Van Calenbergh S; Cordonnier J
    Forensic Sci Int; 2017 Apr; 273():45-52. PubMed ID: 28214755
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro Phase I metabolism of indazole carboxamide synthetic cannabinoid MDMB-CHMINACA via human liver microsome incubation and high-resolution mass spectrometry.
    Presley BC; Logan BK; Jansen-Varnum SA
    Drug Test Anal; 2019 Aug; 11(8):1264-1276. PubMed ID: 31108568
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection and phase I metabolism of the 7-azaindole-derived synthetic cannabinoid 5F-AB-P7AICA including a preliminary pharmacokinetic evaluation.
    Giorgetti A; Mogler L; Haschimi B; Halter S; Franz F; Westphal F; Fischmann S; Riedel J; Pütz M; Auwärter V
    Drug Test Anal; 2020 Jan; 12(1):78-91. PubMed ID: 31476105
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 'Flying high?'-Jump from a height in a 'Spice' high?: A case report on the synthetic cannabinoid 5F-MDMB-P7AICA.
    Walle N; Doerr AA; Schmidt PH; Schaefer N
    Drug Test Anal; 2023 Mar; 15(3):368-373. PubMed ID: 36415074
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical symptoms and blood concentration of new psychoactive substances (NPS) in intoxicated and hospitalized patients in the Budapest region of Hungary (2018-19).
    Institóris L; Kovács K; Sija É; Berkecz R; Körmöczi T; Németh I; Elek I; Bakos Á; Urbán I; Pap C; Kereszty É
    Clin Toxicol (Phila); 2022 Jan; 60(1):18-24. PubMed ID: 34080493
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Emerging Synthetic Cannabinoids: Development and Validation of a Novel Liquid Chromatography Quadrupole Time-of-Flight Mass Spectrometry Assay for Real-Time Detection.
    Krotulski AJ; Mohr ALA; Logan BK
    J Anal Toxicol; 2020 Apr; 44(3):207-217. PubMed ID: 31909808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.